HCV Tier 1 – The Approach to the Patient with HCV Infection (Monograph)

Learning Objectives
- Provide optimal quality of care based on established quality indicators for HCV patients.
- Implement HCV treatment to the fullest extent, ensuring all gaps in treatment are adequately addressed.
- Describe DAA drug therapies so that they may be administered and monitored in HCV patients, in accordance with practice guidelines.
- Implement HCV treatment to the fullest extent, ensuring all gaps in treatment are adequately addressed.
- List three side effects of DAA agents.
- Identify the timeframe for each side effect that may occur.
Course summary
Available credit:
- 0.50 AMA PRA Category 1 Credit(s)™
- 0.50 Attendance
Registration Opens:
01/30/2014
Registration Expires:
01/29/2015
Available Credit
- 0.50 AMA PRA Category 1 Credit(s)™
- 0.50 Attendance

Facebook
X
LinkedIn
Forward